The well-known biological role of IL-24 is to inhibit proliferation and promote apoptosis in a broad spectrum of cancer cells, and phase I clinical trial results suggested that a recombinant adenovirus overexpressing MDA-7/IL-24 (INGN-241) has shown certain clinical benefits for patients [35]. The gene discussed is IL24; the disease is cancer.